Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Bupropion SR | Canagliflozin | |
|---|---|---|
| Category | Pharmaceuticals | Pharmaceuticals |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Strong | Moderate (longevity), Strong (cardiorenal) |
Norepinephrine-dopamine reuptake inhibitor used clinically for mood, motivation, and smoking cessation.
SGLT2 inhibitor originally developed for type 2 diabetes. Blocks glucose reabsorption in kidneys, creating a mild glucose deficit that activates AMPK and mimics caloric restriction. Extended lifespan in male mice in the ITP.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →